CH661283A5 - Verfahren zur herstellung der antibiotika ll-c23024 alpha, beta und jota. - Google Patents

Verfahren zur herstellung der antibiotika ll-c23024 alpha, beta und jota. Download PDF

Info

Publication number
CH661283A5
CH661283A5 CH6216/82A CH621682A CH661283A5 CH 661283 A5 CH661283 A5 CH 661283A5 CH 6216/82 A CH6216/82 A CH 6216/82A CH 621682 A CH621682 A CH 621682A CH 661283 A5 CH661283 A5 CH 661283A5
Authority
CH
Switzerland
Prior art keywords
antibiotic
agar
medium
actinomadura
activity
Prior art date
Application number
CH6216/82A
Other languages
German (de)
English (en)
Inventor
David Paul Labeda
Joseph Jacob Goodman
Donald Bruce Borders
Raymond Thomas Testa
Sidney Kantor
Robert F Jun Kennett
Irwin B Wood
John Henry Edward James Martin
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/313,849 external-priority patent/US4407946A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CH661283A5 publication Critical patent/CH661283A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH6216/82A 1981-10-22 1982-10-21 Verfahren zur herstellung der antibiotika ll-c23024 alpha, beta und jota. CH661283A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/313,849 US4407946A (en) 1981-10-22 1981-10-22 Process for producing antibiotic X-14868A
US37278482A 1982-04-28 1982-04-28

Publications (1)

Publication Number Publication Date
CH661283A5 true CH661283A5 (de) 1987-07-15

Family

ID=26979078

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6216/82A CH661283A5 (de) 1981-10-22 1982-10-21 Verfahren zur herstellung der antibiotika ll-c23024 alpha, beta und jota.

Country Status (17)

Country Link
JP (1) JPH0824593B2 (it)
AR (1) AR229058A1 (it)
AU (1) AU558914B2 (it)
CA (1) CA1198386A (it)
CH (1) CH661283A5 (it)
DE (1) DE3238316A1 (it)
DK (1) DK161332C (it)
ES (1) ES516718A0 (it)
FI (1) FI75187C (it)
FR (1) FR2515207B1 (it)
GB (2) GB2108113B (it)
HU (1) HU190814B (it)
IE (1) IE54813B1 (it)
IL (1) IL66671A (it)
IT (1) IT1197433B (it)
NL (1) NL194396C (it)
SE (2) SE456588C (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78648B (it) * 1982-07-26 1984-09-27 Bristol Myers Co
DE102006028817A1 (de) * 2006-06-21 2007-12-27 Evonik Degussa Gmbh Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4278663A (en) * 1980-01-30 1981-07-14 Hoffmann-La Roche Inc. Antibiotic X-14868A, B, C and D

Also Published As

Publication number Publication date
FI823603L (fi) 1983-04-23
AU8965382A (en) 1983-04-28
SE456588B (sv) 1988-10-17
AR229058A1 (es) 1983-05-31
GB2108113B (en) 1985-08-07
JPH05219980A (ja) 1993-08-31
HU190814B (en) 1986-11-28
IL66671A (en) 1985-11-29
FI823603A0 (fi) 1982-10-21
SE456588C (sv) 1998-04-27
GB2147808A (en) 1985-05-22
GB2147808B (en) 1986-02-19
NL8204069A (nl) 1983-05-16
FI75187B (fi) 1988-01-29
SE8205992L (sv) 1983-04-23
ES8308359A1 (es) 1983-09-16
FR2515207A1 (fr) 1983-04-29
GB2108113A (en) 1983-05-11
AU558914B2 (en) 1987-02-12
DE3238316C2 (it) 1992-01-23
ES516718A0 (es) 1983-09-16
DE3238316A1 (de) 1983-06-01
NL194396C (nl) 2002-03-04
DK462082A (da) 1983-04-23
SE8205992D0 (sv) 1982-10-21
JPH0824593B2 (ja) 1996-03-13
IE822542L (en) 1983-04-22
FI75187C (fi) 1988-05-09
GB8426115D0 (en) 1984-11-21
IT1197433B (it) 1988-11-30
DK161332C (da) 1991-12-09
FR2515207B1 (fr) 1988-10-21
CA1198386A (en) 1985-12-24
IT8249317A0 (it) 1982-10-20
IE54813B1 (en) 1990-02-14
DK161332B (da) 1991-06-24
IL66671A0 (en) 1982-12-31
NL194396B (nl) 2001-11-01

Similar Documents

Publication Publication Date Title
DE68920301T2 (de) Makrolide Verbindungen.
DE3879975T2 (de) Demethylavermectine und herstellung dazu.
US4582822A (en) Antibiotic A80190, pharmaceutical compositions containing same and method of use
JPH0511956B2 (it)
DE2843702A1 (de) Neue antibiotische substanz und ihre herstellung durch zuechtung eines streptomyces
DE69005935T2 (de) Antiparasitisches Mittel.
US4683201A (en) Antibiotic A80190-producing Actinomadura oligospora and process
DE3880845T2 (de) Durch fermentation hergestellte antibiotika.
DE68904348T2 (de) Polyaether-antibiotika.
DE68905838T2 (de) Saures polycyclisches etherantibiotikum mit anticoccidiose- und wachstumsfoerderungsaktivitaet.
DD234031A5 (de) Verfahren zur herstellung von neuen antibiotika ll-d 42067alpha und ll-d 42067beta
DE3782169T2 (de) Verfahren zur herstellung von antibiotica 10381b.
DE3238316C2 (it)
DE3882490T2 (de) Saurer polyzyklischer Äther, verwendbar als Anticoccidiosemittel und als wachstumsförderndes Mittel.
DE3509949C2 (de) Verbindungen und deren Verwendung zur Behandlung von Protozoeninfektionen
DE3785868T2 (de) Tierwachstum foerdernde mittel.
EP0197360B1 (de) Verwendung von Efomycinen als Leistungsförderer bei Tieren, Efomycine und ihre Herstellung
AT388564B (de) Biologisch reine kultur von actinomadura yumaense sp. nov. nrrl 12515 sowie verfahren zur herstellung der neuen antibiotika ll-c23024alpha, beta und jota, zur bekaempfung von nematoden und zur bekaempfung von coccidiosis-infektionen
US4510134A (en) Controlling nematodes in animals and soil with nematocidal antibiotics
EP0011178B1 (de) Antibiotikum, seine Herstellung sowie seine Verwendung als Arzneimittel
EP0011859B1 (de) Urethan-Derivate und deren Salze, die Herstellung dieser Verbindungen, sowie entsprechende Präparate
EP0183214A2 (de) Organisch-chemische Verbindung, mikrobiologische Verfahren zu ihrer Herstellung sowie ihre Verwendung
JPH0784472B2 (ja) 抗生物質ａ８０１９０
DE3250073C2 (de) Verwendung der antibakteriellen Mittel LL-C23024alpha, beta und jota zur Bekämpfung von Nematoden und Coccidiosis-Infektionen
DE69124390T2 (de) Polycyclisches etherantibiotikum mit anticoccidose- und wachstumsförderungsaktivität

Legal Events

Date Code Title Description
PUE Assignment

Owner name: AMERICAN CYANAMID COMPANY TRANSFER- F. HOFFMANN-LA

PUE Assignment

Owner name: F. HOFFMANN-LA ROCHE AG TRANSFER- ALPHARMA (LUXEMB

PL Patent ceased